Aegis Capital Starts Trevi Therapeutics (TRVI) at Buy
Tweet
Share
E-mailGet Alerts TRVI Hot Sheet
Price: $18.48 +0.11%
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Aegis Capital analyst Nathan Weinstein initiates coverage on Trevi Therapeutics (NASDAQ: TRVI) with a Buy rating and a price target of $10.00.
For an analyst ratings summary and ratings history on Trevi Therapeutics click here. For more ratings news on Trevi Therapeutics click here.
Shares of Trevi Therapeutics closed at $2.16 yesterday.
You May Also Be Interested In
- BofA Securities Starts Definium Therapeutics Inc (DFTX) at Buy
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
- Craig-Hallum Starts Horizon Quantum (HQ) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
